Beeh KM - Search Results

1

Cost-effectiveness of tiotropium versus salmeterol: the POET-COPD trial.

Hoogendoorn M, Al MJ, Beeh KM, Bowles D, Graf von der Schulenburg JM, Lungershausen J, Monz BU, Schmidt H, Vogelmeier C, Rutten-van Mölken MP. Hoogendoorn M, et al. Among authors: beeh km. Eur Respir J. 2013 Mar;41(3):556-64. doi: 10.1183/09031936.00027212. Epub 2012 Jun 14. Eur Respir J. 2013. PMID: 22700844 Free article. Clinical Trial.

2

Study design considerations in a large COPD trial comparing effects of tiotropium with salmeterol on exacerbations.

Beeh KM, Hederer B, Glaab T, Müller A, Rutten-van Moelken M, Kesten S, Vogelmeier C. Beeh KM, et al. Int J Chron Obstruct Pulmon Dis. 2009;4:119-25. Epub 2009 Apr 15. Int J Chron Obstruct Pulmon Dis. 2009. PMID: 19436693 Free PMC article. Clinical Trial.

3

Tiotropium versus salmeterol for the prevention of exacerbations of COPD.

Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken MP, Beeh KM, Rabe KF, Fabbri LM; POET-COPD Investigators. Vogelmeier C, et al. Among authors: beeh km. N Engl J Med. 2011 Mar 24;364(12):1093-1103. doi: 10.1056/NEJMoa1008378. N Engl J Med. 2011. PMID: 21428765 Free article. Clinical Trial.

4

Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium.

Beeh KM, Beier J, Donohue JF. Beeh KM, et al. Respir Res. 2012 Jun 22;13(1):52. doi: 10.1186/1465-9921-13-52. Respir Res. 2012. PMID: 22726538 Free PMC article.

5

Effect of tiotropium vs. salmeterol on exacerbations: GOLD II and maintenance therapy naïve patients.

Vogelmeier C, Fabbri LM, Rabe KF, Beeh KM, Schmidt H, Metzdorf N, Glaab T. Vogelmeier C, et al. Among authors: beeh km. Respir Med. 2013 Jan;107(1):75-83. doi: 10.1016/j.rmed.2012.09.015. Epub 2012 Oct 26. Respir Med. 2013. PMID: 23102611 Free article. Clinical Trial.

6

Seasonal distribution of COPD exacerbations in the Prevention of Exacerbations with Tiotropium in COPD trial.

Rabe KF, Fabbri LM, Vogelmeier C, Kögler H, Schmidt H, Beeh KM, Glaab T. Rabe KF, et al. Among authors: beeh km. Chest. 2013 Mar;143(3):711-719. doi: 10.1378/chest.12-1277. Chest. 2013. PMID: 23188489 Clinical Trial.

7

Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial.

Beeh KM, Glaab T, Stowasser S, Schmidt H, Fabbri LM, Rabe KF, Vogelmeier CF. Beeh KM, et al. Respir Res. 2013 Oct 29;14(1):116. doi: 10.1186/1465-9921-14-116. Respir Res. 2013. PMID: 24168767 Free PMC article. Clinical Trial.

8

Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD(®).

Vogelmeier CF, Asijee GM, Kupas K, Beeh KM. Vogelmeier CF, et al. Among authors: beeh km. Adv Ther. 2015 Jun;32(6):537-47. doi: 10.1007/s12325-015-0216-2. Epub 2015 Jun 23. Adv Ther. 2015. PMID: 26100349 Free PMC article. Clinical Trial.

9

[Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].

Beeh KM, Beier J, Buhl R, Stark-Lorenzen P, Gerken F, Metzdorf N; ATEM-Studiengruppe. Beeh KM, et al. Pneumologie. 2006 Jun;60(6):341-6. doi: 10.1055/s-2005-919145. Pneumologie. 2006. PMID: 16761228 Clinical Trial. German.

10

A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study.

Chapman KR, Beeh KM, Beier J, Bateman ED, D'Urzo A, Nutbrown R, Henley M, Chen H, Overend T, D'Andrea P. Chapman KR, et al. Among authors: beeh km. BMC Pulm Med. 2014 Jan 17;14:4. doi: 10.1186/1471-2466-14-4. BMC Pulm Med. 2014. PMID: 24438744 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters